central-nervous-system

Documents about central-nervous-system

• A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)#804998ClinicalTrials.gov
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors#1074576ClinicalTrials.gov
• Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors#905680ClinicalTrials.gov
• Acalabrutinib in CNSL#1095074ClinicalTrials.gov
• Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)#1337473ClinicalTrials.gov
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain#1231257ClinicalTrials.gov
• Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)#857700ClinicalTrials.gov
• A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma#1451710ClinicalTrials.gov
• Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy#873577ClinicalTrials.gov
• Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma#910497ClinicalTrials.gov
• Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma#1282890ClinicalTrials.gov
• Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma#887256ClinicalTrials.gov
• Singapore Neurologic Infections Program#1465535ClinicalTrials.gov
• Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors#839054ClinicalTrials.gov
• Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)#1245691ClinicalTrials.gov
• Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma#1045487ClinicalTrials.gov
• Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma#867369ClinicalTrials.gov
• Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma#1126625ClinicalTrials.gov
• Local Registry of Central Nervous System Infections (ReCeNSI)#1230600ClinicalTrials.gov
• Mapping Draining Lymph Nodes in CNS Malignancies#1231094ClinicalTrials.gov
• Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma#1260107ClinicalTrials.gov
• An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors#847804ClinicalTrials.gov
• Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients#908432ClinicalTrials.gov
• Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors#879196ClinicalTrials.gov
• A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis#1073621ClinicalTrials.gov
• Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors#871399ClinicalTrials.gov
• The 2007 WHO Classification of Tumours of the Central Nervous System#6776OpenAlex
• High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors#451518ClinicalTrials.gov
• a Phase II Study in Primary Central Nervous System Lymphoma#904794ClinicalTrials.gov
• Device-related Central Nervous System Infections in Adult Intensive Care Units in Brazil#1140826ClinicalTrials.gov
• Stem Cells in NF1 Patients With Tumors of the Central Nervous System#1364163ClinicalTrials.gov
• Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors#896569ClinicalTrials.gov
• Establishment of Prevention and Control System of Central Nervous System Infection#871337ClinicalTrials.gov
• High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma#1094269ClinicalTrials.gov
• Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma#1172704ClinicalTrials.gov
• Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma#1260978ClinicalTrials.gov
• Adjunctive Doxycycline for Central Nervous System Tuberculosis#1451680ClinicalTrials.gov
• The Human Brain#1316982Open Library
• Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response#321717ClinicalTrials.gov
• Safety and Efficacy of MultiHance in Pediatric Patients#840831ClinicalTrials.gov
• Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma#1030879ClinicalTrials.gov
• Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection#1112183ClinicalTrials.gov
• PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma#1365570ClinicalTrials.gov
• Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS#387167ClinicalTrials.gov
• A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)#857317ClinicalTrials.gov
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary#6747OpenAlex
• Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System#136318ClinicalTrials.gov
• Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma#868930ClinicalTrials.gov
• Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors#889763ClinicalTrials.gov
• Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma#968376ClinicalTrials.gov